Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Hurtado, AP
  • Mazario, RG

Grupos

Abstract

Background and objectives: Rhupus is a very rare syndrome of overlapping rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), characterized by the presence of erosive polyarthritis associated with symptoms and signs of SLE and the presence of high specificity autoantibodies. The analysis of HLADR molecules would allow us to genetically characterize patients diagnosed with rhupus, being able to differentiate them from the HLA-DR profile of patients with RA and SLE. Materials and methods: Cross-sectional observational study of 9 patients diagnosed with rhupus in whom the HLA-DR genotype was genetically characterized. Results: Rhupus is usually more frequent in women with initial diagnosis of RA. The most frequent clinical manifestations are articular and, serologically, ANA, RF and anti-CCP positivity stand out. The most frequent HLA-DR were HLA-DR1, HLA-DR3, HLA-DR4, HLA-DR7 and HLA-DR13. Conclusions: A higher proportion of HLA-DR1 and DR9 was observed in patients with rhupus compared to RA and SLE, as well as a lower proportion of HLA-DR2, DR6 and DR8, which would help the early characterization of these patients prior to the overlap diagnosis. (c) 2024 Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Copyright © 2024 Elsevier España, S.L.U. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0025-7753, 1578-8989

MEDICINA CLINICA  ELSEVIER ESPANA SLU

Tipo:
Article
Páginas:
16-19
PubMed:
39516107
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,325 SCImago ℠
Cuartil:
Q3 SCImago ℠

Citas Recibidas en Web of Science: 1

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Rhupus syndrome; Overlap syndrome; Rheumatoid arthritis; Systemic lupus erythematosus; HLA-DR; HLA

Cita

Compartir